Dual Modality Treatment Solution for Dermatologists to be Showcased at CDS Annual Meeting 2024, Englewood, CO
Radiant Aura expands office-based radiation therapy treatment options for patients with non-melanoma skin cancers and keloid scarring
Radiant Aura is the only dual modality surface radiation therapy system that enables you to choose either electronic brachytherapy or SRT based on the needs of your patients.
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will showcase Radiant™ Aura at the 2024 Colorado Dermatologic Society (CDS) Annual Meeting at the Hilton Denver Inverness Hotel in Englewood, CO on Sept. 20, 2024.
“We’re pleased to feature Radiant Aura at this year’s CDS Annual Meeting. Radiant Aura is a painless non-surgical skin cancer treatment alternative available to support the delivery of office-based radiation therapy for patients with NMSC when surgery is not possible, contraindicated, or simply not preferred due to cosmetic concerns,” said Adrian Treverton, CEO of Xstrahl.
Radiant Aura is a low-dose, X-ray based system, and is the only dual modality radiation therapy system that offers both non-invasive electronic brachytherapy (eBt) and superficial radiation therapy (SRT) for treating non-melanoma skin cancers (NMSC) and keloid scarring.
Visit Xstrahl at the 2024 CDS Annual Meeting at the Hilton Denver Inverness Hotel in Englewood, CO on Sept. 20, 2024.
# # #
About Xstrahl
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.
To learn more about Radiant Aura, visit www.radiant-therapy.com
To learn more about all Xstrahl clinical and research systems, visit www.xstrahl.com
